Testing for Latent Infection in Tuberculosis Testing Market Spurs Best Control Practices, Valuation to Rise at CAGR of 4.0% from 2019 to 2027: TMR

ALBANY, N.Y., June 9, 2021 /PRNewswire/ -- Tuberculosis testing has advanced continuously over the years to help in the diagnosis of TB and occupies a key role in preventing its transmission. Adoption of infection control practices has propelled healthcare providers in collaboration with government to identify at-risk populations. The high mortality of pulmonary tuberculosis has led to remarkable advancements in culture-based tests.

Tests to identify Mycobacterium tuberculosis in the body, a gold standard for testing, has been extensively helpful in reducing the burden of active tuberculosis. Advances in such tests are expanding the avenue in the tuberculosis testing market. However, Mantoux TST needs a follow-up tests, and has shown limited success in confirming TB disease in the individual. The lack of TST antigen is a key factor for its limited efficacy in developing world.

The global tuberculosis testing market stood at US$ 2.5 Bn in 2018 and is expected to reach US$ 3,399.8 Mn with the CAGR of 4.0% from 2019 to 2027.

Request for Analysis of COVID-19 Impact on Tuberculosis Testing Market – https://www.transparencymarketresearch.com/covid19.php

Key Findings of Tuberculosis Testing Market Study

• Unmet Need in Latent TB detection to Drive Innovations: The tuberculosis treatment market has evolved on the back of focus on targeted testing in at-risk populations. Particularly, the market is seeing new avenues from the use of testing to promote treatment of latent tuberculosis infection which has high worldwide burden. In the U.S. alone, per the CDC, as many as 13 million people are living with latent TB infection.  Case detection for latent TB infections plays a crucial role in reducing tuberculosis prevention, mainly by identifying at-risk populations. In this regard, targeted testing is viewed as an effective approach for reducing the future cases of tuberculosis disease, hereby reducing the burden.

Request Brochure of Tuberculosis Testing Market Report - https://www.transparencymarketresearch.com/brochure.php

• Prevalence of Drug-Resistant Tuberculosis Infection Propels Need for Screening: presence of drug-resistant (DR) tuberculosis pose a massive concern for healthcare systems. Per the WHO, there are over half a million new cases of DR TB that are rifampicin-resistant (RR) and multidrug-resistant (MDR). The worrying thing is that the cohort that had undergone treatment shows poor treatment completion rates. Hence, the agency is regularly updating its MDR-TB treatment guidelines. Players in the TB testing market rely on drug susceptibility testing (DST) to identify the source case of DR-TB.

Purchase the Tuberculosis Testing Market Report - https://www.transparencymarketresearch.com/checkout.php

• Growing Awareness of TB and Affordability of Tests in Hospitals Boosts Market

Developing regions of the world are seeing rise in awareness of the morbidity of TB and the treatment regimens available at low cost. Hospitals are a key site for TB testing, and they are keen on making such tests affordable. This will expand the revenue prospects in the TB testing market.

Tuberculosis Testing Market: Regional Prospects

• Of all the regions, North America held the majority of shares in the global market in 2018
• Strides in bacteriological confirmation, especially screening for drug resistant tuberculosis infection, had made the region generate sizable revenues over the years
• Asia Pacific is expected to see substantially lucrative avenues through 2027
• The growth of the market is likely to be fueled by efforts by NGOs in raising awareness about TB, and launch of better products in the key economies of the region

Request for Custom Research - https://www.transparencymarketresearch.com/custom-research.php

Tuberculosis Testing Market: Key Driving Factors and Avenues

• Growing need for timely treatment is a key factor driving growth in the tuberculosis testing market
• Concerted efforts by healthcare systems in eliminating TB in developed world is a key trend enriching the value chain
• Worldwide, regular updates in guidelines for latent TB infection testing are boosting opportunity for market players

Browse Our Latest Reports - https://www.transparencymarketresearch.com/latest.htm

Tuberculosis Testing Market: Key Participants

• Becton, Dickinson and Company
• Thermo Fisher Scientific, Inc.
• Akonni Biosystems, Inc.
• Oxford Immunotec Ltd.
• QIAGEN
• Danaher Corporation
• F. Hoffmann-La Roche AG

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Anti-infective Drugs Market: https://www.transparencymarketresearch.com/antiinfective-drugs-market.html

Diagnostic Specialty Antibodies Market: https://www.transparencymarketresearch.com/diagnostic-specialty-antibodies-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected] 
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/tuberculosis-testing-market.htm 
Website: https://www.transparencymarketresearch.com/

SOURCE Transparency Market Research